Wen Xiao

机构：Nanjing University of Chinese Medicine, China Pharmaceutical University, Center for Excellence in Molecular Cell Science · ORCID：0000-0002-8300-0107

发表论文 60 篇 · 总被引 659 次 · h-index 14

代表论文

• Allosteric binding sites at the receptor–lipid bilayer interface: novel targets for GPCR drug discovery (2020 · Drug Discovery Today · 被引 59)
• A broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance (2025 · Nature Communications · 被引 19)
• Discovery of a Series of 5-Amide-1 H -pyrazole-3-carboxyl Derivatives as Potent P2Y 14 R Antagonists with Anti-Inflammatory Characters (2022 · Journal of Medicinal Chemistry · 被引 18)
• Cytochrome P450 Enzyme-Mediated Bioactivation as an Underlying Mechanism of Columbin-Induced Hepatotoxicity (2020 · Chemical Research in Toxicology · 被引 18)
• Carabrone Attenuates Metabolic Dysfunction–Associated Steatohepatitis by Targeting STAT3 in Mice (2025 · MedComm · 被引 12)
• Discovery of a Series of 4-Amide-thiophene-2-carboxyl Derivatives as Highly Potent P2Y 14 Receptor Antagonists for Inflammatory Bowel Disease Treatment (2024 · Journal of Medicinal Chemistry · 被引 12)